Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Symbiotec Pharmalab IPO: From Issue Details to Financials; Here’s What You Need to Know
42+ min ago (1029+ words) by Nikhil Naik | August 24, 2026 7:30 am Synopsis: Symbiotec Pharmalab Limited’s Rs. 1,757 crore IPO opens on August 24, 2026. The company plans to use the fresh issue proceeds mainly to repay borrowings and for general corporate purposes, supported by its strong position in corticosteroid…...
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
21+ min ago (201+ words) The Manila Times Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics Through its entry into Lilly Gateway Labs, Rznomics plans to accelerate candidate discovery and development across its target gene database bank comprising over 200 disease targets,…...
Werewolf Therapeutics And Ambros Therapeutics Merge With $150 Million PIPE To Advance Phase III CRPS Drug Neridronate
25+ min ago (728+ words) Werewolf Therapeutics and Ambros Therapeutics have entered into a definitive all-stock merger agreement alongside an oversubscribed $150 million private placement that is expected to fund development of neridronate through pivotal Phase III results and a planned FDA submission. The combined company…...
Biobook Begins Advisory Role in GC Green Cross Open Innovation Project... Supporting Discovery of Promising Biotech Startups
1+ hour, 50+ min ago (212+ words) Published 24 Aug.2026 09:51(KST) Biobook announced on August 24 that it has been selected as the implementing partner for the GC Green Cross Open Innovation Project organized by North Chungcheong Province and the Osong Medical Innovation Foundation, and has begun its advisory…...
2 Biotech Stocks Shaping Up for Major Breakouts
1+ day, 7+ hour ago (168+ words) Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts....
AMGN 260821 480.00P (AMGN260821P480000) Stock Options Chain | Quotes & News
6+ day, 15+ hour ago (10+ words) Moomoo...
Certain Warrants of ProQR Therapeutics N.V. are subject to a Lock-Up Agreement Ending on 24-AUG-2026.
2+ hour, 2+ min ago (158+ words) marketscreener.com Certain Warrants of ProQR Therapeutics N.V are subject to a Lock-Up Agreement Ending on 24-AUG-2026 These Warrants will be under lockup for 60 days starting from 25-JUN-2026 to 24-AUG-2026.Details:The officers and directors have agreed that, during the…...
AMGN 260821 387.50C (AMGN260821C387500) Stock Options Chain | Quotes & News
6+ day, 14+ hour ago (10+ words) Moomoo...
Certain Common Stock of Absci Corporation are subject to a Lock-Up Agreement Ending on 24-AUG-2026.
2+ hour, 4+ min ago (133+ words) marketscreener.com Certain Common Stock of Absci Corporation are subject to a Lock-Up Agreement Ending on 24-AUG-2026 These Common Stock will be under lockup for 61 days starting from 24-JUN-2026 to 24-AUG-2026.Details:Officers and directors have agreed, subject to specified…...
Certain Common Stock of ProQR Therapeutics N.V. are subject to a Lock-Up Agreement Ending on 24-AUG-2026.
2+ hour, 3+ min ago (161+ words) marketscreener.com Certain Common Stock of ProQR Therapeutics N.V are subject to a Lock-Up Agreement Ending on 24-AUG-2026 These Common Stock will be under lockup for 60 days starting from 25-JUN-2026 to 24-AUG-2026.Details:The officers and directors have agreed that,…...